FDA 510(k) Clearance for Bone Bolt Fracture Repair System
Bone Bolt implants are used to treat challenging bone fractures, such as pelvic fractures and fractures of the long bones...
Jul 27, 2023,
FDA 510(k) Clearance for Bone Bolt Fracture Repair System
Carmell Therapeutics Merges with Axolotl Biologix
Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair and orthopedic indications....
Jul 27, 2023,
icotec Gains 510(k) for VADER Pedicle System Navigated Instruments
The newly cleared Navigation set includes a comprehensive range of instruments, for both Open and MIS surgery....
Jul 27, 2023,
Proprio Raises $43M Series B Funding
The capital fuels commercialization to address demand for Proprio's AI-driven surgical navigation platform in the U.S. and overseas....
Jul 27, 2023,
First U.S. Commercial Case with CartiHeal Agili-C
CartiHeal announced the first commercial implantation of Agili-C in the U.S. The Agili-C implant features a bi-phasic design that supports both...
Jul 26, 2023,
Total Joint Orthopedics Gains 510(k) for Klassic Knee Cemented Femoral Stem
The clearance also addresses designs of femoral augments, tibial augments and revision cones, signaling the first step for TJO to...
Jul 26, 2023,
Spinal Stabilization Technologies to be Publicly Listed
SST's flagship product, the PerQdisc, is a lumbar intervertebral disc nucleus replacement....
Jul 25, 2023,
EpiBone to Start Clinical Trials for Lab-Grown Knee Cartilage
The engineered allogenic osteochondral graft has shown promise in preclinical studies and could benefit people with damaged knee cartilage caused...
Jul 25, 2023,
DePuy Synthes Sales Accelerated in First Half
The company grew 5% in the second quarter of 2023 as it sustained its recent run of improved orthopedic sales...
Jul 24, 2023,
Executives Talk Highs and Lows of Orthopedic Enabling Technology
We asked three orthopedic CEOs about the opportunities and challenges in the orthopedic enabling technology space....
Jul 21, 2023,
Loading new posts...
No more posts
